Zymeworks, Inc. (ZYME)
29.19
-0.71
(-2.37%)
USD |
NASDAQ |
Sep 04, 16:00
29.20
+0.01
(+0.03%)
After-Hours: 20:00
Zymeworks Cash and Short Term Investments (Annual) : 228.80M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 228.80M |
| December 31, 2024 | 225.78M |
| December 31, 2023 | 374.33M |
| December 31, 2022 | 492.23M |
| December 31, 2021 | 252.61M |
| December 31, 2020 | 426.35M |
| Date | Value |
|---|---|
| December 31, 2019 | 298.90M |
| December 31, 2018 | 200.16M |
| December 31, 2017 | 87.80M |
| December 31, 2016 | 40.26M |
| December 31, 2015 | 15.16M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Theravance Biopharma, Inc. | 315.36M |
| BridgeBio Pharma, Inc. | 588.03M |
| Aprea Therapeutics, Inc. | 14.60M |
| ACADIA Pharmaceuticals, Inc. | 819.69M |
| Alnylam Pharmaceuticals, Inc. | 2.908B |